August 11 – Stigma Reduction

Robert Childs, MPH is currently a JBS International Technical Expert Lead (TEL), focusing on providing technical assistance on rural overdose prevention projects across the United States. Prior to working at JBS International, he worked as the North Carolina Harm Reduction Coalition’s (NCHRC) Executive Director from 2009 to 2018, where he oversaw the agency’s operations, program implementation, and innovations.

At NCHRC he specialized in harm reduction practice, overdose prevention and response initiatives, drug policy advocacy & reform, media affairs, jail based health interventions, Law Enforcement Assisted Diversion (also known as Let Everyone Advance with Dignity or LEAD) and law enforcement occupational safety and drug overdose response. Mr. Childs also helped develop the largest syringe service program network and community and law enforcement-based naloxone distribution programs in the Southern United States during his tenure there. Mr. Childs also worked with NCHRC in leading the campaigns that led to the passage of comprehensive 911 Good Samaritan and naloxone bills in 2013, 2015, and 2017 and passage of syringe decriminalization, biohazard collection, and syringe service program bills in 2013, 2015, 2016, and 2017.

In addition, he helped start the South’s first LEAD program in Fayetteville (2016) and helped set up other programs throughout North Carolina and in other states. He has been invited to speak at the United Nations, U.S. Congress, Office of National Drug Control Policy, Food and Drug Administration, and multiple state legislatures on his work.  His work has been featured in the New York Times, Lancet, People, Wall Street Journal, USA Today, Daily Beast, Kaiser Health News, Fox News, NBC News, ABC News, Human Rights Watch, Governing, Morbidity and Mortality Weekly Report, NPR, and Huffington Post.

In his spare time Robert spends a lot of time hiking and swimming in lower Appalachia with his children and volunteers with local naloxone distribution efforts to people who use drugs.

This session will only be held virtually